ABSTRACT The intestinal tract harbors a diverse community of microbes that have co-evolved with the host immune system. Although many of these microbes execute functions that are critical for host physiology, the host immune system must control the microbial community so that the dynamics of this interdependent relationship is maintained. To facilitate host homeostasis, the immune system ensures that the microbial load is tolerated, but anatomically contained, while remaining reactive to microbial invasion. Inflammation is the most prevalent manifestation of host defense in reaction to alterations in tissue homeostasis and is elicited by innate immune receptors that recognize and detect infection, host damage, and danger signaling molecules that activate a highly regulated network of immunological and physiological events for the purpose of maintaining homeostasis and restoring functionality. The efficacy, duration, and consequences of an inflammatory response is dependent upon the type of trigger that is recognized by the innate immune receptors. Further, because of different triggers, there are multiple phenotypes of inflammation. Physiological inflammation is the homeostatic balance between tolerance of the microbiota and the reactivity to pathogen invasion. Pathologic inflammation is usually an acute response that involves the host response to toxins and infection often resulting in collateral damage to surrounding tissue and increased metabolic energy use. Metabolic inflammation is a chronic low-grade inflammation generated by excessive nutrient intake and the metabolic surplus fosters metabolic dysfunction by integrating signals from both the immune and metabolic systems. Sterile inflammation is a low-grade chronic inflammation, in the absence of an infection, in response to chemical, physical, and metabolic stimuli. With a sterile inflammatory response, the stimulus persists without being eliminated suggesting that collateral damage is the cause of the disease. The common denominator with all intestinal inflammatory phenotypes is the central role of the gut microbiota whether it be microbial balance and diversity of microbial metabolic production or microbial turnover.
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INTRODUCTION
Other than "alternatives to antibiotics," gut health is undoubtedly one of the most used phrases in the collective scientific lexicon of animal industries and research (Cummings et al., 2004; . The gut and its integral components are functionally dependent for the proper physiological development of the host. As the organ with the largest surface area with constant interaction with the environment, the gut must provide an effective barrier function (epithelial lining), which reduces exposure to environmental toxins and potential pathogenic microbes yet allows for nutrient absorption and waste secretion (Turner, 2009; Mwangi et al., 2010; Oakley et al., 2014; Oakley and Kogut, 2016) . The intestinal milieu is complex that provides a platform for the growth of a diverse microbiota that serves as not only a second barrier against colonization by pathogens, but which also regulates immune development and maturation, and provides metabolites for host nutrition (Gaggia et al., 2010; Wigley, 2013; Sargeant et al., 2014; Smith et al., 2014; Roberts et al., 2015) . Lastly, the gut contains a large number of neurons, gut hormones, and secondary messengers that regulate a number of host physiological functions (Neumann et al., 2015; Cani and Knauf, 2016; Weber, 2017) .
For purposes of this review, we will concentrate on the immune component of the intestine, namely the inflammatory responses and the role that different types of inflammation plays in the function and dysfunction 2339 of gut health. Recent reviews can provide a more comprehensive overview on other components of gut health (Broom and Kogut, 2017; Kogut et al., 2018) .
INTESTINAL IMMUNITY
The intestinal immune system has a much more complex function than the systemic immune response yet is highly effective at contending with the plethora of pathogens to which livestock are continually exposed while simultaneously initiating and maintaining an immune tolerance to the commensal intestinal microbiota (Abraham and Medzhitov, 2011 ). An effective intestinal immune system is needed for rapid response to environmental insults, as well as, intestinal health and maintenance of proper tissue physiological homeostasis. This balance makes the intestinal immune response/responsiveness unique as both features must function simultaneously during homeostasis.
Host Defenses
Host intestinal defenses are made-up of a series of barriers, most of which are components of innate immunity (Hooper, 2009; Belkaid and Harrison, 2017) . These barriers function to segregate the commensal microbiota and potential pathogens in the luminal side of the intestinal epithelium and to remove and kill any that do penetrate the barrier (Hooper, 2009) . The first barrier is the microbial barrier that consists of a diverse community of microbes that have co-evolved with the host immune system. Most of these microbes execute functions that are vital for the homeostasis of host physiology while the host provides a nutrient-rich environment for microbes to live. However, the host controls this microbial community in order to maintain the interdependent nature of the interaction. During intestinal homeostasis, the microbial barrier induces a series of microbial, immunological, and metabolic interactions with the host that generate conditions unfavorable for colonization by enteric pathogens in a phenomenon known as colonization resistance (Buffie and Pamer, 2013; Lawley and Walker, 2013) . The second barrier is a chemical barrier. This barrier consists of a double mucus layer that covers the entire intestinal epithelium; the upper mucus layer provides an environment for commensal bacteria to survive (microbial barrier). The inner mucus layer remains relatively sterile area through the production of antimicrobial peptides and secretory IgA by specialized cells in the epithelium (Ramanan and Cadwell, 2016; Belkaid and Harrison, 2017) . Next is a physical barrier provided by the intestinal epithelial cells. The epithelium includes enterocytes, goblet cells that synthesize and release mucin, Paneth cells that synthesize antimicrobial peptides), and intestinal stem cells. Linking the epithelial cells are tight junctions, which help form a continuous luminal surface and help seal the intercellular space from the external environment of the intestinal lumen. These tight junctions are formed by protein (claudins, occludins and zona occludens protein 1) complexes. In addition, secretory IgA, produced by intestinal B cells, provide an additional protective layer from the luminal bacteria (Yurong et al., 2005) . The last barrier underlying the epithelial tight junctions is an immunological barrier in the lamina propria using a number of immune cells (macrophages, dendritic cells, various subsets of T cells [Th1, Th2, Th17, Treg] , intraepithelial lymphocytes, γδT cells) and molecules (cytokines and chemokines) (Hooper, 2009, Belkaid and Harrison, 2017) . Dendritic cells present antigens to naïve CD4+ T cells present in gut Peyer's patches and cecal tonsils, where differentiation of the effector CD4+ T cell subsets occurs (Hooper, 2009, Belkaid and Harrison, 2017) .
Tolerance
As part of maintaining host homeostasis, the immune system tolerates the diverse microbial community while keeping the microbes anatomically in check in the intestine, while simultaneously remaining responsive to microbial attempts to breach the intestinal barrier and invade the host (Hooper, 2009; Belkaid and Harrison, 2017) . Further, the microbiota is required for intestinal immune development while immune responses regulate the structure and composition of the intestinal microbiota (Belkaid and Harrison, 2017) . Gut immune responses are tightly controlled to remain tolerant of the commensal microbiota, while concurrently maintaining the capacity to respond appropriately to harmful insults. Several cellular and molecular mechanisms have evolved to contribute to effective balance (homeostasis), while attenuating damaging overreactions or altering the metabolic functions of the microbiota (dysbiosis).
INFLAMMATION
Poultry live in a milieu full of microbes and environmental danger signals (Gallucci and Matzinger, 2001 ). Every day they are exposed to untold numbers of potentially pathogenic and non-pathogenic environmental insults through the air, water and food they consume, and contact with house mates, resulting in the activation of the gastrointestinal innate immune system. Inflammation is the most prevalent manifestation of host defense in reaction to alterations in tissue homeostasis (Medzhitov, 2008) . Inflammation is elicited by innate immune receptors (see discussion below) that recognize and detect infection, host damage, and danger signaling molecules that activate a highly regulated network of immunological and physiological events for the purpose of maintaining homeostasis and restoring functionality (Chovatiya and Medzhitov, 2013) . Activation of the innate responses directs the production of a number of cells and pro-inflammatory molecules crucial to controlling most infectious and non-infectious challenges (Nathan, 2002; Barton, 2008) . Inflammation and the return to physiological homeostasis rely on signaling pathways induced by innate immune receptors Kogut and Arsenault, 2017) . Enterocytes and innate immune cells (macrophages, granulocytes, dendritic cells) found diffusely in the epithelium and lamina propria express pattern recognition receptors (PRRs), including tolllike receptors (TLRs) and Nod-like receptors (NLRs), that sense conserved pathogen molecular signatures (Keestra et al., 2013) . The TLRs and NLRs remain relatively non-responsive to the myriad of commensal microbiota during homeostasis, but during infection, injury, or another environmental insult, the PRRs initiate a cascade of events that contribute to the induction of an inflammatory response (Keestra et al., 2013; Smith et al., 2014) . Innate immune sensing, mediated through the PRRs, initiate various immune pathways that mediate microbial killing and activate the acquired immune effector cells while keeping the resident microbiota in check without generating an overt inflammatory response. The PRRs, located on the surface and subcellular compartments of the epithelial cell barrier and on cells of the innate immune response, recognize and bind to the evolutionarily conserved molecular constituents (microbe-associated molecular patterns [MAMPs] ) of infectious microbes (Fearon and Locksley, 1996; Janeway, 1997a, 2000) . MAMPs are molecular structures shared by large groups of pathogens that are conserved products of microbial metabolism not subject to antigenic variability (Fearon and Locksley, 1996) . They are required for either the survival or pathogenicity of the microbe and are distinct from any host antigens. MAMPs include lipopolysaccharide (LPS) of all gram-negative bacteria, peptidoglycan (PGN) of gram-positive bacteria, double stranded viral RNA, mannans of yeast cell walls, unmethylated CpG motifs of prokaryotic DNA, lipoproteins, and the glycolipids of mycobacteria (Fearon and Locksley, 1996; Janeway, 1997a, 1997b) . Further, recent evidence has demonstrated that endogenous host molecules (non-pathogen-derived) released from stressed or dying cells, such as intracellular heat shock proteins and nucleic acids, called danger (or damage) associated molecular patterns (DAMPs) are also recognized by PRRs that promote inflammatory pathways (Medzhitov, 2010; Land, 2017; Wu and Chen, 2014) .
Inflammation is an adaptable response that adjusts to the conditions of a particular environment such as tissue injury or malfunction, excessive nutrients and metabolites, toxins, or infection (Sansonetti and Medzhitov, 2009; Garrett et al., 2010; Hotamisligil, 2017) resulting in a large range of inflammatory reactions (Table 1 ). The animal production industries are most familiar with gut inflammation as a pathological process associated with a decrease in weight gain, feed intake, feed efficiency, survivability, and uniformity (Roura et al., 1992; Gaskins, 2008; Kogut, 2013; Iseri and Klasing, 2014) . However, recent research has shown that inflammation, although tightly regulated, displays phenotypic plasticity that is dependent upon the "trigger" that activates the response (Medzhitov, 2008; Ashley et al., 2012) . For example, even under homeostatic conditions, the gut is continually exposed to a multitude of exogenous antigenic, dietary and toxic stimuli, as well as, endogenous stimuli such as structural bacterial components (lipopolysaccharides and peptidoglycans) and bacterial-derived metabolites from bacterial microbiota, all of which induce a low-grade stimulation of the innate immune system through TLRs and NLRs that is continuously regulated and contained, thus preventing intestinal tissue damage. This controlled inflammatory response has been defined as "physiological inflammation" (Smith and NaglerAnderson, 2005; Fiocchi, 2008) and is dependent upon the balance of the innate immune response that mediates host defense and tolerance in the gut. However, the induction of an infection resulting in an increase in pathogenic microbe-specific molecules (MAMPs) and/or virulence factors or cell debris from tissue injury (DAMPs) would transform physiological inflammation to "pathological inflammation" or classical inflammation (Barton, 2008; Medzhitov, 2008) .
INDUCTION OF INFLAMMATORY PHENOTYPES

Physiological Inflammation
Under homeostatic conditions, the immune system in the intestine concurrently performs two different functions: (1) defense against pathogen organisms and prevention of access by the intestinal microflora and (2) maintains a state of tolerance to the commensal microbes in the gut (Mezhitov, 2008; Abraham and Medzhitov, 2011) . This continuous monitoring of the microbiota involves the constitutive physical and biochemical barriers of the mucus layer, epithelial cell layer and secreted antimicrobial peptides, as well as, the immunological barrier of the immune cells dispersed in the intestinal mucosa and secretory IgA released from plasma cells also in the intestinal mucosa (Abraham and Medzhitov, 2011) . During physiological inflammation or as described by Abranham and Medzhitov (2011) immune homeostasis, the immune tolerance in the intestine to the resident microbiota and food antigens is preferential to activation of an inflammatory response.
During physiological inflammation, the intestinal microbiome and the intestinal immune system exist in a symbiotic homeostasis sharing a bi-directional relationship, with both elements influencing each other's development, composition, and functionality (Nicolson et al., 2012) . The normal host immune defenses that prevent pathogen invasion of the intestine also play a functional role in tolerance. Tolerance still involves the activation of PRRs initiated by the continuous release of LPS and PGNs from the cell walls of commensal bacteria as well as other gut bacterial-derived products (MAMPs) and bacterial metabolites, such as short chain fatty acids and polysaccharide A which drive down inflammation (Pedra et al., 2009; Takeuchi and Akira, 2010; Abraham and Medzhitov, 2011) . However, the PRRs that are activated are found on unique populations of innate immune cells that regulate the PRR-mediated signaling pathways that alter PRR responsiveness, induce the production of high levels of regulatory proteins such as interleukin-(IL-) 10 and transforming growth factor-β, and induce the differentiation of the T-regulatory subpopulation of T lymphocytes (Abraham and Medzhitov, 2011; Kinnebrew and Pamer, 2012) .
Pathological Inflammation
When an acute microbial infection or tissue injury occurs, the host defense-tolerance balance is disturbed and physiological inflammation converts to a true inflammatory response or pathological inflammation (Barton, 2008; Medzhitov, 2008) . A number of cell types in the intestinal tissue express PRRs, especially TLRs and NLRs, that recognize the various triggers of inflammation (Nathan, 2002; Medzhitov, 2007; Takeda et al., 2003; Bianchi 2007 ). The primary inducers of pathological inflammation are the MAMPs found on microbial pathogens, pathogen virulence factors, DAMPS, such as ATP and nucleic acids, normally found intracellular, but are released into the extracellular space following tissue injury and cell death, and commensal gut bacterial-derived products and bacterial metabolites (Bianchi, 2007; Barton, 2008; Medzhitov, 2008; Rock and Kono, 2008) .
Sterile Inflammation
A low-grade chronic inflammation, in the absence of an infection, in response to a chemical (oxidative stress), physical (microbiota-derived components), and metabolic stimuli (non-starch polysaccharides [NSPs] from dietary components) is known as sterile inflammation (Rubartelli et al., 2013) . With a sterile inflammatory response, the stimulus persists without being eliminated suggesting that collateral damage is the cause of the disease (Rock et al., 2010) . In sterile inflammation, PRRs recognize microbiome-derived components like LPS, peptidoglycan (PGN), and bacterial DNA (CpG) following microbiome bacterial cell wall turnover or bacterial lysis, but also DAMPs released from host cells after oxidative stress induced cell death (Rock et al., 2010) .
Further, certain ingredients used in commercial broiler diets contain dietary NSPs that are indigestible by poultry, but represent a potential energy source which can be utilized with the proper addition of exogenous enzymes (Meng et al., 2005) For example, soybean meal (SBM) is a primary source of vegetable protein that contains around 3% soluble NSP and 16% insoluble NSP (Irish and Balnave, 1993) , consisting mainly of mannans and galactomannans (Slominski, 2011) .
β-mannan is similar in structure to surface components of multiple pathogenic microbes and is recognized by a specific PRR, the mannose receptor, that stimulates the intestinal innate immune system leading to a purposeless energy draining immune response called feedinduced immune response (FIIR) (Hsiao et al., 2006; Martinez-Cummer, 2015) . In addition, gliadin, a component of cereal (e.g., wheat) gluten, has been shown to alter expression of tight junction proteins and increase intestinal permeability, which has been implicated to contribute to the induction of inflammation (de Punder and Pruimboom, 2015) .
Each meal leads to postprandial (low-grade) inflammatory response in the intestine, the magnitude of which is related to the caloric, value-specific components. If not properly regulated, postprandial inflammation could lead to unwanted consequences such as muscle catabolism, inappetite, and predisposition to infections (Margioris, 2009; Niewold, 2014) . However, standard feed ingredients in U.S. commercial broiler diets, such as soybean, sesame, and sunflower meal, contain the immunogenic indigestible NSP. Dietary NSP are indigestible by poultry, but do represent a potential valuable energy source that can be utilized by the birds with the addition of enzymes to the diet (Meng et al., 2005) . Unfortunately, many of these NSP can be recognized by host PRR, for example the mannose receptor, recognizes the major NSP in soybean meal, β-galactomannan (Hsaio et al., 2006) . Recognition of these NSP by PRRs can lead to a chronic feed-induced inflammation resulting in a nonproductive energy expenditure on immunity. The addition of exogenous enzymes to the diet, such as β-mannases, phytases, and amylases, enhance NSP-containing feed not only by increasing digestion, but also by reducing the feed-induced immune response, because the NSP are no longer recognized by PRR as demonstrated recently (Ferriera et al., 2016; Arsenault et al., 2017) .
Finally, the largest potential source of endogenous triggers of sterile inflammation in the intestine are the 10 7 to 10 11 bacteria/g in the microbiota. For example, peptidoglycan (PGN) is the foremost component of gram-positive bacterial cell walls as well as being present in gram-negative bacterial cells walls (McDonald et al., 2005) . Likewise, LPS (gramnegative bacterial cell wall) and unmethylated CpG oligodeoxynucleotide of all prokaryotic DNA are all ligands of host TLR and NLRs (He et al., 2011; Keestra et al., 2013) . Both PGN and LPS are shed when bacteria in the microbiota divide and all components are released upon bacterial lysis (Myhre et al., 2006) . Under homeostatic conditions, these components play a role in physiological inflammation. However, under stress conditions, such as FIIR, oxidative and heat stress, or feeding diets with high levels of NSPs that increased feed passage time and or decrease intestinal motility, as well as the frequency of reverse peristalsis, results in prolonging the exposure to these triggers resulting in the induction of a lowgrade sterile inflammatory response (Sacranie et al., 2007) .
Metabolic-Inflammation
A chronic low-grade inflammation generated by excessive nutrient intake and the metabolic surplus fosters metabolic dysfunction by activating the same signaling transduction molecules and pathways as immune responses to infections (Hotamisligil, 2006) . Metabolic dysfunction appears to take center stage by integrating signals from both the immune and metabolic systems (Kogut, 2013) . Further, Humphrey and colleagues (2014) believed that "in modern broiler breeds, the drive toward improved productivity and carcass conformity has a negative impact on immune regulation in the gut, microbiota dysbiosis, and a persistent nutrient excess (fatty acids and carbohydrates) that result in chronic systemic inflammation, poorly controlled local and systemic inflammation, and increased metabolic diseases." This metabolic or meta-inflammation due to modern genetic/management practices for growing broilers and turkeys are virtually identical to those characteristics that lead to metabolic diseases in humans as a result of chronic low-grade inflammation, i.e., increased muscle mass, increased fat deposition, high metabolic rate, ingesting high nutrient dense diets, and consuming food at a high rate, just to name a few (Hotamisligil, 2006; Hotamisligil and Erbay, 2008; Gregor and Hotamisligil, 2011) .
The innate immune cell recognition system and immune cell metabolism have coevolved and share the same signal transduction pathways (Assamann and Finlay, 2016) . Thus, nutrient excess from diets can result in overloads of metabolites that act as DAMPs that can be sensed by PRRs of the innate immune system (Land, 2015; Assamann and Finlay, 2016; Lackey and Olefsky, 2016) , thereby simulating a chronic inflammation. PRRs, such as TLR4 and NLRP3, act as metabolite sensors activated by different metabolite DAMPS including free fatty acids, carbohydrates, and lipids (Gregor and Hotsamisligil, 2011) . Continuous activation of these PRRs through excessive nutrient intake leads to the production of pro-inflammatory cytokines, such as IL-1β and IL-6, which maintain the low-grade inflammatory response.
Lastly, when nutrient excess leads to activation of PRR-mediated inflammation, there is a concurrent increase in metabolic pathways in the mitochondria of activated immune cells Tannahil et al., 2013) that results in the overproduction of various metabolites via the Krebs cycle (succinate, citrate, NAD + ) and glycolysis (lactate) Tannehil et al., 2013; Tretter, Patocs, and Chinopoulas, 2016) . All four metabolites have been shown to be signals for multiple inflammatory mediators that result in a low-grade chronic inflammation (Tannahil et al., 2013; Loftus and Finlay, 2016) . Increased succinate production results in an increase in stabilization of the transcription factor hypoxia inducible factor (HIF-1α) (Tannahil et al., 2013; Pucino et al., 2017) . The stabilization of HIF-α results in increased glycolysis and the persistent production of the pro-inflammatory cytokine IL-1β (Tannahil et al., 2013; Loftus and Finlay, 2016) . Likewise, citrate is also increased via the Kreb's cycle and is a signal for the increased production of inflammatory mediators such as reactive oxygen species, nitric oxide, and prostaglandins (Infantino et al., 2011) . Lactate is a waste product produced in the immune cell cytoplasm at the end of glycolysis that affects local T cell immunity by inhibiting T cell motility, inducing the change of CD4+ cells to Th17 pro-inflammatory T cell subset that leads to the production of IL-17, which is a hallmark of chronic inflammation (Haas et al., 2016) .
CONCLUSIONS AND PERSPECTIVES
Inflammation is the coordinated response of the innate immune system following recognition of noxious stimuli by cellular PRRs. These stimuli can be of microbial (e.g., MAMPs) or non-microbial (e.g., host metabolites) origin and the inflammatory response seeks to maintain or restore tissue homeostasis. Managing inflammation in the intestine is a particularly delicate balance as normal physiological inflammation represents a homeostatic equilibrium between tolerance of the commensal gut microbiota and reactivity to pathogen invasion. When this balance is disturbed (e.g., from increased noxious stimuli), an acute inflammatory response can ensue that is referred to as pathological inflammation, which can result in collateral damage and increased metabolic/nutrient cost. Sterile and metabolic inflammation are, typically, chronic, low-grade inflammatory states resulting from innate immune system stimulation by non-infectious cellular components and metabolites. Ideally, maintaining normal physiological inflammation and limiting other inflammatory triggers/states is the optimum scenario. However, features of modern animal production (e.g., increased feed intakes and nutrient excesses) are more likely to predispose these animals to, particularly chronic, inflammatory triggers/states, which may be minimized by thoughtful dietary strategies, including the use of enzymes (e.g., mannanase) to reduce dietary components (e.g., mannans) that maybe recognized by PRRs. We must, however, remember that PRR ligands are not uniform in structure and may initiate differing downstream signaling/effects. For example, TLR4 recognizes LPS but both pathogenic and commensal bacteria can alter their LPS structures to modulate TLR4 signaling/immunological consequences (Rosadini and Kagan, 2017) . Similarly, β-glucans are components of both microbes and cereals, but with quite differing structures (and possibly other characteristics), which could influence their immunomodulatory effects (Volman et al., 2008) . In addition, non-nutritive components (e.g., oral antibiotics) have been implicated in the development of inflammatory disorders. Recent work by Knoop et al. (2016) reported that various oral antibiotics, even at continuous low-dose, subtherapeutic levels, promoted the translocation of (commensal) bacteria across the intestinal epithelium and inflammatory responses, which was linked with decreased microbial signals to goblet cells and the formation of associated antigen passages. Interestingly, there is also emerging evidence that such bacteria may contribute to a significant population of dormant bacteria in blood (potentially "hiding" in leucocytes and erythrocytes) (Kell and Pretorius, 2015) . These bacteria may subsequently be resuscitated and thus proliferate, providing a continual pool of immunogenic cell wall components, such as LPS, that induce chronic, low-grade (systemic) inflammation. These observations highlight the complexity of PRR and ligand interaction/signaling, influences of dietary (both nutritive and non-nutritive) components on intestinal state, and links to systemic inflammation.
We can also consider specific cellular signaling pathways in the regulation and potential modulation of (intestinal) inflammation. Recently, it has been shown that that an important innate immune pathway, regulated by endoplasmic reticulum-associated protein (STING; simulator of IFN genes), may be involved in controlling inflammation (Ahn et al., 2017) . Ahn et al. (2017) reported that commensal gut microbes can influence STING signaling, particularly in mononuclear phagocytes, to produce both pro-and anti-inflammatory cytokine expression to support gut homeostasis. Dysregulation of STING signaling may contribute to damaging intestinal inflammation and thus targeting this pathway may provide opportunities to influence inflammatory processes in both humans and animals, which may include promoting enhanced STING expression to inhibit (e.g., avian) viruses (Cheng et al., 2015) . Similarly, (pro-resolving) molecules that help regulate, and promote resolution of, inflammation, such as lipoxins, resolvins, etc., may warrant particular interest. As such, these molecules (e.g., lipoxins secreted by immune cells such as neutrophils and macrophages), help maintain and restore tissue homeostasis through, for example, promoting the recruitment and subsequent clearance of neutrophils from the site of inflammation (Chandrasekharan and Sharma-Walia, 2015) . Pro-resolving molecules remain under evaluation for treating inflammatory-disorders in humans and these learnings may subsequently be applied to animal production.
This review has outlined differences between intestinal inflammatory phenotypes and factors that influence their expression or progression. Innate, inflammatory responses are critical intestinal and systemic immune defenses. However, their initiation and duration are not always helpful or necessary, whereas appropriate promotion may enhance disease resistance, and so their regulation is the focus of much research interest. Methods are available to reduce/eliminate unnecessary inflammatory responses, and include choice of feed ingredients, use of enzymes, etc., while other factors (e.g., subtherapeutic oral antibiotics) that may promote intestinal and systemic inflammation should be reviewed. Ongoing research is helping to identify key molecules and pathways that are involved in the control and resolution of inflammation, and how these can be appropriately modulated, which will prove invaluable in helping optimize future poultry production.
